Dr. John Oertle of Envita Medical Centers Outlines the Transforming Potential of Precision Oncology on the 'Finding Genius' Podcast
With appropriate precision-targeted treatments, it is possible to live cancer-free for decades, even after an aggressive stage 4 cancer diagnosis. “The technology exists; it's just a matter of actually unleashing it,” said Dr. John Oertle, Chief Medical Director of Envita Medical Centers. Speaking to Richard Jacobs on his podcast, Dr. Oertle explained how one of their first few patients, diagnosed with stage 4 colon cancer in 2001, continues to live cancer-free, despite being given a 20% chance of survival by standard oncology.
Highlighting the potential of the innovative precision-integrative oncology approach followed at Envita, Dr. Oertle stated that a detailed analysis of the root causative factors triggering the disease in each individual patient widens the toolkit of options. To enhance patient outcomes, Dr. Oertle and his team of specially trained physicians utilize a personalized combination of genetically targeted treatments. These personalized treatments include a combination of targeted chemotherapy, immunotherapy agents, and custom compounded adjuvants.
Going beyond the scope of standard one-size-fits-all treatment protocols, Envita's team focuses on a multipronged approach to target cancerous cells and their causative triggers while rebuilding the immune system for lasting outcomes. Dr. Oertle explained how Envita's approach has the potential to be a game changer in the treatment and prevention of cancer. “But unfortunately, too many times, people make decisions based on insufficient data,” said Dr. Oertle, lamenting the lives lost to cancer due to a lack of access to precision oncology care.
To learn more about the potential of precision medicine in treating not just cancer, but also enhancing your overall wellness, and about ways to incorporate this advanced care into self-funded plans, tune into this podcast.
